Literature DB >> 3112226

Regulation of murine T cell proliferation by B cell stimulatory factor-1.

K H Grabstein, L S Park, P J Morrissey, H Sassenfeld, V Price, D L Urdal, M B Widmer.   

Abstract

The proliferation of mitogen-activated primary T cells, antigen-activated memory T cells from mixed leukocyte culture, and antigen-dependent alloreactive T cell clones in response to purified murine recombinant B cell stimulatory factor-1 (also known as interleukin 4) was examined. We found that B cell stimulatory factor-1 (BSF-1) stimulated optimal proliferation of these T cells only after their recent activation by antigen or mitogen. Analysis of cell surface BSF-1 receptor expression indicated that although T cell activation is accompanied by a small increase in BSF-1 receptor expression, the cells also express BSF-1 receptors prior to activation at a time when they do not proliferate in response to BSF-1. BSF-1 was as effective a stimulus as interleukin 2 for inducing proliferation of the Lyt-2+ subpopulation of concanavalin A-activated murine spleen cells and an alloreactive cytolytic T cell clone. However, the L3T4+ subpopulation of concanavalin A-activated spleen and an alloreactive helper T cell clone were less responsive to BSF-1 than to interleukin 2. Taken together, the data indicate an important role for BSF-1 in the regulation of normal T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112226

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Authors:  K Fujihashi; M N Kweon; H Kiyono; J L VanCott; F W van Ginkel; M Yamamoto; J R McGhee
Journal:  Springer Semin Immunopathol       Date:  1997

Review 2.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

3.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.

Authors:  H Saito; K Hatake; A M Dvorak; K M Leiferman; A D Donnenberg; N Arai; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Interleukin 2 (IL-2) and interleukin 7 (IL-7) reciprocally induce IL-7 and IL-2 receptors on gamma delta T-cell receptor-positive intraepithelial lymphocytes.

Authors:  K Fujihashi; S Kawabata; T Hiroi; M Yamamoto; J R McGhee; S Nishikawa; H Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.

Authors:  G Thyphronitis; G C Tsokos; C H June; A D Levine; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

7.  Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Authors:  N I Obiri; J P Siegel; F Varricchio; R K Puri
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

Authors:  M B Widmer; R B Acres; H M Sassenfeld; K H Grabstein
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line.

Authors:  L S Park; D J Friend; A E Schmierer; S K Dower; A E Namen
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  A role for interleukin 4 in the differentiation of mature T cell receptor gamma/delta + cells from human intrathymic T cell precursors.

Authors:  A Bárcena; M L Toribio; L Pezzi; C Martínez
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.